MedTrace Logo

in Vitro Evaluation of the Anti-fibrotic Activity of Adipose Tissu-derived Stromal Vascular Fraction Used as a Medicinal Treatment for Scarred Vocal Folds

NCT06823908 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2025-04-10

No results posted yet for this study

Summary

This is a single-center, prospective study, aimed at investigating the anti-fibrotic in vitro activity of the stromal vascular fraction of patients with scarred vocal cord.

Conditions

  • Vocal Cord Injuries

Interventions

OTHER

Reuse of surgical waste

Heathly donnors will be received in the plastic surgery department as part of routine care. They will be informed of the study and their surgical waste (adipose tissue) will be recovered specifically for this research.

OTHER

Reuse of biological samples

Patients included in the cellcordes 2 trial who have given their consent for the re-use of their biological samples (Stromal Vascular Fraction) in other clinical research projects, and who have been informed of the cellcordes bio study.

Sponsors & Collaborators

  • Aix Marseille Université

    collaborator OTHER

  • Assistance Publique Hopitaux De Marseille

    lead OTHER

Principal Investigators

  • MATTEI Alexia, Doctor · assistance publique - hôpitaux de Marseille

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2027-04-30
Completion
2027-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06823908 on ClinicalTrials.gov